These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7296756)
1. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene. Amin S; Juchatz A; Furuya K; Hecht SS Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756 [TBL] [Abstract][Full Text] [Related]
2. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. Hecht SS; Rivenson A; Hoffmann D Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979 [TBL] [Abstract][Full Text] [Related]
3. Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene. Amin S; Camanzo J; Hecht SS Cancer Res; 1984 Sep; 44(9):3772-8. PubMed ID: 6547637 [TBL] [Abstract][Full Text] [Related]
4. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene. Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989 [TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism and DNA binding of 6-nitro-5-methylchrysene and 5-methylchrysene. Shiue GH; el-Bayoumy K; Hecht SS Carcinogenesis; 1987 Sep; 8(9):1327-31. PubMed ID: 3621469 [TBL] [Abstract][Full Text] [Related]
6. Tumor-initiating activity and metabolism of polymethylated phenanthrenes. LaVoie EJ; Bedenko V; Tulley-Freiler L; Hoffmann D Cancer Res; 1982 Oct; 42(10):4045-9. PubMed ID: 7105001 [TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497 [TBL] [Abstract][Full Text] [Related]
8. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism. el-Bayoumy K; Amin S; Hecht SS Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952 [TBL] [Abstract][Full Text] [Related]
9. 1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene. Hecht SS; LaVoie E; Mazzarese R; Amin S; Bedenko V; Hoffmann D Cancer Res; 1978 Jul; 38(7):2191-4. PubMed ID: 350385 [TBL] [Abstract][Full Text] [Related]
10. High stereoselectivity in mouse skin metabolic activation of methylchrysenes to tumorigenic dihydrodiols. Amin S; Huie K; Balanikas G; Hecht SS; Pataki J; Harvey RG Cancer Res; 1987 Jul; 47(14):3613-7. PubMed ID: 3594428 [TBL] [Abstract][Full Text] [Related]
11. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene. Hecht SS; LaVoie EJ; Bedenko V; Pingaro L; Katayama S; Hoffmann D; Sardella DJ; Boger E; Lehr RE Cancer Res; 1981 Nov; 41(11 Pt 1):4341-5. PubMed ID: 7306963 [TBL] [Abstract][Full Text] [Related]
12. Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene. Amin S; Hecht SS; Di Raddo P; Harvey RG Cancer Lett; 1990 May; 51(1):17-20. PubMed ID: 2337893 [TBL] [Abstract][Full Text] [Related]
13. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen. Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691 [TBL] [Abstract][Full Text] [Related]
14. 5-Methylchrysene metabolism in mouse epidermis in vivo, diol epoxide--DNA adduct persistence, and diol epoxide reactivity with DNA as potential factors influencing the predominance of 5-methylchrysene-1,2-diol-3,4-epoxide--DNA adducts in mouse epidermis. Melikian AA; LaVoie EJ; Hecht SS; Hoffmann D Carcinogenesis; 1983; 4(7):843-9. PubMed ID: 6872139 [TBL] [Abstract][Full Text] [Related]
15. Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity. Weyand EH; He ZM; Ghodrati F; Wu Y; Marshall MV; LaVoie EJ Chem Biol Interact; 1992 Sep; 84(1):37-53. PubMed ID: 1394615 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and DNA binding of 5,6-dimethylchrysene in mouse skin. Misra B; Amin S; Hecht SS Chem Res Toxicol; 1992; 5(2):242-7. PubMed ID: 1643254 [TBL] [Abstract][Full Text] [Related]
17. Identification of metabolites of 5,11-dimethylchrysene and 5,12-dimethylchrysene and the influence of a peri-methyl group on their formation. Amin S; Camanzo J; Hecht SS Carcinogenesis; 1982; 3(10):1159-63. PubMed ID: 7172414 [TBL] [Abstract][Full Text] [Related]
18. Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons. Hecht SS; Amin S; Rivenson A; Hoffmann D Cancer Lett; 1979 Nov; 8(1):65-70. PubMed ID: 509421 [TBL] [Abstract][Full Text] [Related]
19. The effects of bay-region methyl substitution on 6-nitrochrysene mutagenicity in Salmonella typhimurium and tumorigenicity in newborn mice. el-Bayoumy K; Shiue GH; Amin S; Hecht SS Carcinogenesis; 1989 Sep; 10(9):1685-9. PubMed ID: 2670305 [TBL] [Abstract][Full Text] [Related]
20. A hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 5-hydroxymethylchrysene. Okuda H; Hiratsuka A; Nojima H; Watabe T Biochem Pharmacol; 1986 Feb; 35(3):535-8. PubMed ID: 3456226 [No Abstract] [Full Text] [Related] [Next] [New Search]